Gary Clark: Unfiltered

Insightful analysis on the financial currents, corporate maneuvers, and innovations defining our era.

GC
Editor
Gary Clark

About This Column

Gary Clark is a commentator and strategist exploring the intersection of finance and industrial transformation. Transitioning from his deep dive into corporate maneuvers, Gary now delivers daily dispatches on the broad forces defining the 2026 economic landscape - from the evolution of global supply chain finance to the impact of AI on asset allocation. With a reputation for providing "the story behind the numbers," he offers a unique lens on what drives market performance in a complex world. His writing is essential for anyone seeking to understand the "why" of today’s market to predict the "what" of tomorrow.

Displaying items 81-100 of 988 in total

The Mitchell Doctrine: P&G's Radical Shift in Global Marketing

Read full article
The Mitchell Doctrine: P&G's Radical Shift in Global Marketing

EXEL's Triple Threat: A Bellwether for the 2026 Economic Downturn

Read full article
EXEL's Triple Threat: A Bellwether for the 2026 Economic Downturn

Fashion's New Nexus: Vegas Marketplace Signals a Tectonic Shift in Retail

Read full article
Fashion's New Nexus: Vegas Marketplace Signals a Tectonic Shift in Retail

ALP's European Gamble: A Nicotine Disruptor Fueled by Media and Muscle

Read full article
ALP's European Gamble: A Nicotine Disruptor Fueled by Media and Muscle

Colony's Merger-Ready Quarter Hides a High-Wire Balancing Act

Read full article
Colony's Merger-Ready Quarter Hides a High-Wire Balancing Act

Beyond the Payout: MetLife's Irish Gambit Redefines Employee Benefits

Read full article
Beyond the Payout: MetLife's Irish Gambit Redefines Employee Benefits

ChristianaCare's Epic Gambit: A High-Stakes Digital Health Transformation

Read full article
ChristianaCare's Epic Gambit: A High-Stakes Digital Health Transformation

Oncotelic's Nanotech Paper: A Blueprint for De-risking Drug Assets

Read full article
Oncotelic's Nanotech Paper: A Blueprint for De-risking Drug Assets

NOVAGOLD Forges a U.S. Gold Titan, Seizing Full Control of Donlin

Read full article
NOVAGOLD Forges a U.S. Gold Titan, Seizing Full Control of Donlin

Spectrum's Power Play: NYI Absorption Reshapes NYC's Ad Landscape

Read full article
Spectrum's Power Play: NYI Absorption Reshapes NYC's Ad Landscape

Beyond the Hype: Claritev's Bet on AI Accountability Signals Market Shift

Read full article
Beyond the Hype: Claritev's Bet on AI Accountability Signals Market Shift

Meta's Green Demand Powers a New Wave of U.S. Solar Infrastructure

Read full article
Meta's Green Demand Powers a New Wave of U.S. Solar Infrastructure

The Five-Minute Fix for America's Workforce Crisis?

Read full article
The Five-Minute Fix for America's Workforce Crisis?

The Pope, The Scientist, and The New Currency of Trust

Read full article
BriefGlance

Ranger Energy's Q2 Test: A Bellwether for U.S. Oil Services

Read full article
Ranger Energy's Q2 Test: A Bellwether for U.S. Oil Services

PEI's Construction Boom Cools: A Test of Strategy and Retention

Read full article
PEI's Construction Boom Cools: A Test of Strategy and Retention

Lockheed's PAC-3 ACE: A Bet on Affordability in Modern Warfare

Read full article
Lockheed's PAC-3 ACE: A Bet on Affordability in Modern Warfare

Bridgemarq Sacrifices Yield for Dominance in a Tech-Driven Shake-Up

Read full article
BriefGlance

Brilliant Earth's Moment of Truth: Can Ethics Outshine Economic Headwinds?

Read full article
Brilliant Earth's Moment of Truth: Can Ethics Outshine Economic Headwinds?

AI at the Cribside: AAP and OpenEvidence Rewire Pediatric Medicine

Read full article
AI at the Cribside: AAP and OpenEvidence Rewire Pediatric Medicine
UCID: 7